Clinical Trial Update: Efficacy and Safety of L Arginine to Prevent Preeclampsia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluated the efficacy and safety of L-Arginine to prevent preeclampsia. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: Hospital Civil Juan I. Menchaca | Conditions: Preeclampsia | Phase 3 | Status: COMPLETED